Please ensure Javascript is enabled for purposes of website accessibility

What Does Wall Street See for Laboratory Corp. of America Holdings's Q1?

By Seth Jayson - Updated Apr 10, 2017 at 1:50PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Checking expectations

Laboratory Corp. of America Holdings (NYSE: LH) is expected to report Q1 earnings around April 19. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Laboratory Corp. of America Holdings's revenues will grow 1.8% and EPS will increase 9.9%.

The average estimate for revenue is $1.45 billion. On the bottom line, the average EPS estimate is $1.77.

Revenue details
Last quarter, Laboratory Corp. of America Holdings logged revenue of $1.41 billion. GAAP reported sales were 2.9% higher than the prior-year quarter's $1.37 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $1.54. GAAP EPS of $1.26 for Q4 were 6.0% lower than the prior-year quarter's $1.34 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 38.3%, 190 basis points worse than the prior-year quarter. Operating margin was 20.8%, 190 basis points better than the prior-year quarter. Net margin was 8.6%, 130 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $5.79 billion. The average EPS estimate is $7.13.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 668 members out of 690 rating the stock outperform, and 22 members rating it underperform. Among 209 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 205 give Laboratory Corp. of America Holdings a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Laboratory Corp. of America Holdings is hold, with an average price target of $93.28.

Is Laboratory Corp. of America Holdings the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Laboratory Corporation of America Holdings Stock Quote
Laboratory Corporation of America Holdings
LH
$242.45 (-1.85%) $-4.58

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.